JNJ vs BIIB
By Alex · Tickerpine
Johnson & Johnson vs Biogen Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | BIIB |
|---|---|---|
| Price | $273.14 | $220.77 |
| Market cap | $658.24B | $32.62B |
| P/E ratio | 31.7 | 38.7 |
| ROE | 25.74% | 4.58% |
| Profit margin | 21.48% | 8.32% |
| Revenue growth | 6.60% | 3.40% |
| Dividend yield | 1.96% | — |
| Beta | 0.23 | 0.16 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs BIIB in plain English
- JNJ is the bigger company — about 20.2× the market cap of BIIB.
- JNJ is cheaper on earnings (P/E 31.7 vs 38.7).
- JNJ earns a higher return on equity (26% vs 5%).
- JNJ is growing revenue faster (7% vs 3%).
- JNJ pays a dividend (1.96%) while the other effectively doesn't.
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
BIIB return calculator
See what $1,000 in Biogen Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.